Third Quarter 2024 Results Key Financial Results Revenue: US$33.3m (up 48% ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $62.5, a high ...

Q3 2024 Earnings Call Transcript November 6, 2024 Operator: Good morning and welcome to Sixth Street Specialty Lending, ...

Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) missed analyst estimates by 40%. Looking ahead, revenue ...

Q3 2024 Earnings Call Transcript November 5, 2024 Operator: Good morning, everyone, and welcome to the Cellectis Third ...

Enticed by a reward of $1 million, a former police officer helped a foreign scam syndicate use Singapore as a conduit to ...

Reports Q3 revenue $175.7M, consensus $157.3M. The company said, “For the third quarter and first nine months of 2024, strong performance ...

Third quarter net product revenues for ZORYVE® (roflumilast) franchise of $44.8M, with $22.0M for ZORYVE cream 0.3%, $20.3M for ZORYVE topical ...

Bruce, Professional Relations Associate, 3M Pharmaceuticals, personal communication, March 2007). Of interest to us were the four subjects (15%) with reactions to fragrance mix. The positive ...